Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The interaction between nonsteroidal anti-inflammatory drugs (NSAIDs) and Helicobacter pylori remains controversial. We retrospectively investigated whether H. pylori infection exacerbates severe gastric mucosal injury among chronic NSAID users. Methods: From January 2010 to December 2013, a total of 245 long-term NSAID (including low-dose aspirin) users who had undergone an esophagogastroduodenoscopy and had been evaluated for H. pylori infection were enrolled at Okayama University Hospital and Tsuyama Chuo Hospital. The degree of gastric mucosal injury was assessed according to the modified Lanza score (MLS). Severe gastric mucosal injury was defined as an MLS ≥4. Univariate and multivariate logistic regression analyses were performed. Results: In the univariate analysis, age ≥75 years (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.3 to 4.2), H. pylori-positivity (OR, 2.0; 95% CI, 1.2 to 3.5), and the concomitant use of proton pump inhibitors (PPIs) (OR, 0.48; 95% CI, 0.26 to 0.86) were significantly associated with severe gastric mucosal injury. The multivariate analysis was adjusted by age and sex and demonstrated that H. pylori-positivity (OR, 1.8; 95% CI, 1.0 to 3.3) and the concomitant use of PPIs (OR, 0.53; 95% CI, 0.28 to 0.99) significantly contributed to severe gastric mucosal injury. Conclusions: H. pylori infection exacerbates severe gastric mucosal injury among chronic NSAID users.
Abstract
Background/Aims: The interaction between nonsteroidal anti-inflammatory drugs (NSAIDs) and Helicobacter pylori remains controversial. We retrospectively investigated whether H. pylori infection exacerbates severe gastric mucosal injury among chronic NSAID users. Methods: From January 2010 to December 2013, a total of 245 long-term NSAID (including low-dose aspirin) users who had undergone an esophagogastroduodenoscopy and had been evaluated for H. pylori infection were enrolled at Okayama University Hospital and Tsuyama Chuo Hospital. The degree of gastric mucosal injury was assessed according to the modified Lanza score (MLS). Severe gastric mucosal injury was defined as an MLS ≥4. Univariate and multivariate logistic regression analyses were performed. Results: In the univariate analysis, age ≥75 years (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.3 to 4.2), H. pylori-positivity (OR, 2.0; 95% CI, 1.2 to 3.5), and the concomitant use of proton pump inhibitors (PPIs) (OR, 0.48; 95% CI, 0.26 to 0.86) were significantly associated with severe gastric mucosal injury. The multivariate analysis was adjusted by age and sex and demonstrated that H. pylori-positivity (OR, 1.8; 95% CI, 1.0 to 3.3) and the concomitant use of PPIs (OR, 0.53; 95% CI, 0.28 to 0.99) significantly contributed to severe gastric mucosal injury. Conclusions: H. pylori infection exacerbates severe gastric mucosal injury among chronic NSAID users.
참고문헌 (33)
- Huang JQ, "Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis", Lancet, 359, pp.14~22 (2002)
- Nishikawa K, "Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population", Eur J Gastroenterol Hepatol, 12, pp.635~640 (2000)
- Lanza FL, "Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications", Am J Gastroenterol, 104, pp.728~738 (2009)
- Malfertheiner P, "Peptic ulcer disease", Lancet, 374, pp.1449~1461 (2009)
- Elliott SL, "Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH", Clin Exp Pharmacol Physiol, 23, pp.432~434 (1996)
- Nishino M, "Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers", Dig Dis Sci, 55, pp.1627~1636 (2010)
- McColl KE, "Helicobacter pylori gastritis and gastric physiology", Gastroenterol Clin North Am, 29(viii), pp.687~703 (2000)
- Iijima K, "Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level", J Gastroenterol, 47, pp.1290~1297 (2012)
- Fukuzawa M, "Correlation between Helicobacter pylori infection and low-dose aspirin use on damage of the upper gastrointestinal tract", J Gastroenterol Hepatol, 27(3), pp.76~81 (2012)
- Venerito M, "Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers", Helicobacter, 15, pp.239~250 (2010)
- Lanza FL, "Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury: effect of scoring method", Dig Dis Sci, 35, pp.1494~1499 (1990)
- Kimura K, "An endoscopic recognition of the atrophic border and its significance in chronic gastritis", Endoscopy, 1, pp.87~97 (1969)
- Iijima K, "Association of gastric acid and mucus secretion level with low-dose aspirin-induced gastropathy", J Gastroenterol, 47, pp.150~158 (2012)
- Dixon MF, "Classification and grading of gastritis: the updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994", Am J Surg Pathol, 20, pp.1161~1181 (1996)
- Sasazuki S, "Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study", Cancer Epidemiol Biomarkers Prev, 15, pp.1341~1347 (2006)
- Yamamoto T, "Diagnosis of Helicobacter pylori infection using RAPIRUN H. pylori antibody detection kit", Expert Rev Mol Diagn, 8, pp.565~569 (2008)
- Kubota K, "Studies of 13C-urea breath test for diagnosis of Helicobacter pylori infection in patients after partial gastrectomy", Digestion, 65, pp.82~86 (2002)
- Chan FK, "Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage", Eur J Gastroenterol Hepatol, 14, pp.1~3 (2002)
- Iijima K, "Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy", J Gastroenterol, 46, pp.612~619 (2011)
- Katelaris PH, "Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men", Gut, 34, pp.1032~1037 (1993)
- Papatheodoridis GV, "Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review", Clin Gastroenterol Hepatol, 4, pp.130~142 (2006)
- Konturek SJ, "From nerves and hormones to bacteria in the stomach: Nobel prize for achievements in gastrology during last century", J Physiol Pharmacol, 56, pp.507~530 (2005)
- Alderman BM, "Insights into the mechanisms of gastric adaptation to aspirin-induced injury : a role for regenerating protein but not trefoil peptides", Lab Invest, 83, pp.1415~1425 (2003)
- Konturek JW, "Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans", Gastroenterology, 114, pp.245~255 (1998)
- Laine L, "Double-blind randomized trials of single-tablet ibuprofen", high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers, 2012, pp.107, 379~386
- Nema H, "Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy", World J Gastroenterol, 16, pp.5342~5346 (2010)
- Miyake K, "Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis : the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine", Aliment Pharmacol Ther, 21(2), pp.67~72 (2005)
- Bianchi Porro G, "Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users: response to omeprazole dual therapy", Gut, 39, pp.22~26 (1996)
- Hawkey CJ, "Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention", Lancet, 352, pp.1016~1021 (1998)
- Chan FK, "Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen", N Engl J Med, 344, pp.967~973 (2001)
- Pilotto A, "Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects", Aliment Pharmacol Ther, 14, pp.1077~1082 (2000)
- Lai KC, "Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial", Aliment Pharmacol Ther, 17, pp.799~805 (2003)
- Iijima K, "Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication", Gut, 46, pp.20~26 (2000)